Newborn Screening in Japan-2021 - Toshihiro Tajima - Grāmatas - Mdpi AG - 9783036529240 - 2022. gada 21. janvāris
Ja vāks un nosaukums nesakrīt, pareizs ir nosaukums

Newborn Screening in Japan-2021

Cena
€ 42,99

Pasūtīts no attālās noliktavas

Paredzamā piegāde . gada 30. okt. - . gada 13. nov.
Ziemassvētku dāvanas var atgriezt līdz 31. janvārim
Saņemiet paziņojumus par jauniem Toshihiro Tajima izdevumiem
Pievienot savam iMusic vēlmju sarakstam

Not rated yet

"Newborn Screening in Japan-2021" is a topical collection of the International Journal of Neonatal Screening. Japan's newborn mass screening (NBS) was started in 1977 at the national level as a national project. Subsequently, screening was conducted for six diseases. From 2014 a tandem mass analyzer (tandem mass) was introduced nationwide, and in addition to the conventional amino acid metabolism disorders urea cycle disorders, organic acid metabolism disorders and fatty acid metabolism disorders have joined the target diseases. Screening is currently conducted for 20 diseases. The acceptance rate of mass screening in Japan is 100%, and top-level screening measures available in the world, such as a quality control system and an inspection system, are carried out. This book is an overview of the history, current status and future of NBS in Japan. I hope that readers are interested in this book.

Mediji Grāmatas     Hardcover Book   (Grāmata ar cieto muguriņu un vāku)
Izlaists 2022. gada 21. janvāris
ISBN13 9783036529240
Izdevēji Mdpi AG
Lapas 116
Izmēri 170 × 244 × 11 mm   ·   453 g
Valoda Angļu  

Vairāk no tā paša izdevēja